Phase 1 Relapsed Adult AML Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19
Relapsed Adult AML
University Hospital, Lille5 enrolled1 locationNCT06649227
Recruiting
Phase 1
CLL-1 CAR-NK Cells for Relapsed/Refractory AML
Refractory AMLRelapsed Adult AML
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine24 enrolled1 locationNCT06307054
Recruiting
Phase 1Phase 2
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome With Excess Blasts-2Leukemia, Myeloid, Acute+2 more
Aptose Biosciences Inc.240 enrolled34 locationsNCT03850574
Recruiting
Phase 1
Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia
Relapsed Adult AML
Pacylex Pharmaceuticals35 enrolled1 locationNCT06613217